Atossa Therapeutics Inc Insider Trading
ATOS
No open-market buying or selling by insiders.
The last open-market buy by an executive or director was in May 2025.
Get an email when ATOS's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| May 21, 2025 | Steven C Quay President & CEO | Bought | 11,239 | $0.88 | 10K | 45% | Form 4 |
| Mar 26, 2025 | H. Lawrence Remmel Director | Bought | 10,000 | $0.70 | 7K | 3891% | Form 4 |
- May 21, 2025Steven C QuayPresident & CEO · bought 11,239 at $0.8810K45% of stake
- Mar 26, 2025H. Lawrence RemmelDirector · bought 10,000 at $0.707K3891% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with ATOS
Spot a number that looks wrong? Check it in ATOS's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ATOS
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.